Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.

Michiel S. Van Der Heijden*, Guru Sonpavde, Thomas Powles, Andrea Necchi, Mauricio Burotto, Michael Schenker, Juan Pablo Sade, Aristotelis Bamias, Philippe Beuzeboc, Jens Bedke, Jan Oldenburg, Gurkamal Chatta, Yüksel Ürün, Dingwei Ye, Zhisong He, Begoña P. Valderrama, Ja Hyeon Ku, Yoshihiko Tomita, Jeiry Filian, Lily WangDaniela Purcea, Miraj Y. Patel, Federico Nasroulah, Matthew D. Galsky

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

122 Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab plus Gemcitabine-Cisplatin in Advanced Urothelial Carcinoma.'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science